查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967815

2026-2034年全球血液透析血管移植市場規模、佔有率、趨勢和成長分析報告

Global Hemodialysis Vascular Grafts Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計血液透析血管移植市場將從 2025 年的 2.8677 億美元成長到 2034 年的 4.3282 億美元，2026 年至 2034 年的複合年成長率為 4.68%。

由於慢性腎臟病和末期腎功能衰竭的盛行率不斷上升，全球血液透析血管移植市場正經歷穩定成長。血管移植對於建立可靠的血管通路以進行長期透析治療至關重要。人口老化以及糖尿病和高血壓盛行率的上升是主要推動因素。

成長要素包括移植材料的技術進步、生物相容性的提升以及抗感染能力的增強。透析中心的擴建和開發中國家醫療保健服務的改善也支持了市場需求。然而，血栓症和感染疾病等併發症仍然是影響臨床療效的挑戰。

展望未來，透過合成和生物工程技術實現移植材料的創新有望提高其耐久性和患者安全性。腎臟護理基礎設施投資的增加將進一步推動市場需求。隨著全球腎臟疾病發生率的持續上升，血管移植材料解決方案將繼續在治療通訊協定中發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球血液透析血管移植物市場：依原料分類

  • 市場分析、洞察與預測
  • 聚酯纖維
  • 聚四氟乙烯
  • 聚氨酯
  • 生物材料

第5章 全球血液透析血管移植市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診治療中心
  • 其他

第6章 全球血液透析血管移植市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • WL Gore & Associates
    • CR BardInc
    • Terumo Medical Corporation
    • LeMaitre VascularInc
    • Getinge AB
    • Vascular Genesis
    • InnAVasc MedicalInc
    • CryoLifeInc
    • Merit Medical SystemsInc
    • Proteon TherapeuticsInc
簡介目錄
Product Code: VMR11210722

The Hemodialysis Vascular Grafts Market size is expected to reach USD 432.82 Million in 2034 from USD 286.77 Million (2025) growing at a CAGR of 4.68% during 2026-2034.

The global hemodialysis vascular grafts market is witnessing steady growth due to the rising prevalence of chronic kidney disease and end-stage renal disease. Vascular grafts are essential for establishing reliable vascular access for long-term dialysis treatment. Aging populations and increasing incidence of diabetes and hypertension are key contributing factors.

Growth drivers include technological advancements in graft materials, improved biocompatibility, and better infection resistance. Expanding dialysis centers and improved healthcare access in developing countries support market demand. However, complications such as thrombosis and infection remain challenges for clinical outcomes.

Looking ahead, innovation in synthetic and bioengineered graft materials is expected to enhance durability and patient safety. Growing investment in renal care infrastructure will further strengthen demand. As global kidney disease rates continue to rise, vascular graft solutions will remain critical in treatment protocols.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Raw Materials

  • Polyester
  • Polytetrafluoroethylene
  • Polyurethane
  • Biological Materials

By End User

  • Hospitals
  • Ambulatory Care Centers
  • Others

COMPANIES PROFILED

  • WL Gore Associates, CR Bard, Inc, Terumo Medical Corporation, LeMaitre Vascular, Inc, Getinge AB, Vascular Genesis, InnAVasc Medical, Inc, CryoLife, Inc, Merit Medical Systems, Inc, Proteon Therapeutics, Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMODIALYSIS VASCULAR GRAFTS MARKET: BY RAW MATERIALS 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Raw Materials
  • 4.2. Polyester Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Polytetrafluoroethylene Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Polyurethane Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Biological Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMODIALYSIS VASCULAR GRAFTS MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Ambulatory Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMODIALYSIS VASCULAR GRAFTS MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Raw Materials
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Raw Materials
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Raw Materials
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Raw Materials
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Raw Materials
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEMODIALYSIS VASCULAR GRAFTS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 W.L. Gore & Associates
    • 8.2.2 C.R. BardInc
    • 8.2.3 Terumo Medical Corporation
    • 8.2.4 LeMaitre VascularInc
    • 8.2.5 Getinge AB
    • 8.2.6 Vascular Genesis
    • 8.2.7 InnAVasc MedicalInc
    • 8.2.8 CryoLifeInc
    • 8.2.9 Merit Medical SystemsInc
    • 8.2.10 Proteon TherapeuticsInc